Health Care & Life Sciences » Medical Equipment & Supplies | Hemagen Diagnostics Inc.

Hemagen Diagnostics Inc. | Cash Flow

Fiscal year is October-September. All values USD Thousands.
2008
2009
2010
2011
2012
Net Income before Extraordinaries
427.20
808.10
156.30
880.50
907.30
Depreciation, Depletion & Amortization
107.60
156.70
163.90
185.80
164.30
Other Funds
729.60
340.90
5.80
87.20
96.60
Funds from Operations
194.90
310.50
13.40
607.50
646.50
Changes in Working Capital
460.30
327.30
196.60
270.30
287.80
Net Operating Cash Flow
265.50
16.80
183.20
337.20
358.70
Capital Expenditures
368.40
114.90
74.10
56.40
91.00
Sale of Fixed Assets & Businesses
8.80
51.80
40.90
2.80
-
Net Investing Cash Flow
184.60
146.90
176.80
156.40
56.00
Issuance/Reduction of Debt, Net
38.80
222.90
30.90
271.40
307.50
Net Financing Cash Flow
38.80
222.90
30.90
271.40
307.50
Net Change in Cash
92.20
57.50
4.60
61.90
147.30
Free Cash Flow
103.00
98.10
257.30
393.60
449.70
Other Sources
175.00
210.00
210.00
210.00
35.00
Exchange Rate Effect
27.50
116.60
32.70
28.80
40.10
Miscellaneous Funds
0.00
0.00
0.00
0.00
0.00

About Hemagen Diagnostics

View Profile
Address
9033 Red Branch Road
Columbia Maryland 21045
United States
Employees -
Website http://www.hemagen.com
Updated 07/08/2019
Hemagen Diagnostics, Inc. is a biotechnology company. It develops, manufactures, and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. Its product lines include Virgo, which consist of various diagnostic test kits that are used to aid in the diagnosis of certain autoimmune and infectious diseases, using ELISA, Immunoflourescence, and hemagglutination technology; and Analyst product line, an Food and Drug Administration-cleared Benchtop Clinical Chemistry Analyzer System, including consumables that are used to measure important constituents in human and animal blood.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.